These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9680493)

  • 21. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
    Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
    Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of giant pituitary adenomas: strategies and results in a series of 95 consecutive patients.
    Mortini P; Barzaghi R; Losa M; Boari N; Giovanelli M
    Neurosurgery; 2007 Jun; 60(6):993-1002; discussion 1003-4. PubMed ID: 17538372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of neuronavigation in transnasal transsphenoidal pituitary surgery.
    Thomale UW; Stover JF; Unterberg AW
    Zentralbl Neurochir; 2005 Aug; 66(3):126-32; discussion 132. PubMed ID: 16116555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study.
    Honegger J; Ernemann U; Psaras T; Will B
    Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of pituitary adenomas.
    Jane JA; Laws ER
    Singapore Med J; 2002 Jun; 43(6):318-23. PubMed ID: 12380732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intracranial metastasis of pituitary adenoma: a case report].
    Taya K; Terao T; Nakazaki H; Sawauchi S; Numoto RT; Murakami S; Yamaguchi Y; Hashimoto T; Abe T
    No Shinkei Geka; 2004 Mar; 32(3):279-84. PubMed ID: 15148803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender-related differences in non-functioning pituitary adenomas.
    Schaller B
    Neuro Endocrinol Lett; 2003 Dec; 24(6):425-30. PubMed ID: 15073569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Relationship between invasive pituitary adenomas and cavernus sinus and cariod artery and surgical outcomes].
    Ren ZY; Yang Y; Su CB; Wang RZ; Tao W; Ma WB; Li YN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):13-7. PubMed ID: 15782485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67.
    Knosp E; Kitz K; Perneczky A
    Neurosurgery; 1989 Dec; 25(6):927-30. PubMed ID: 2601824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis in rat somatotrophin-secreting pituitary adenoma cells by bromocriptine.
    Yin D; Kondo S; Takeuchi J; Morimura T
    Oncol Res; 1993; 5(9):383-7. PubMed ID: 8038459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pituitary adenoma: a radiotherapeutic perspective.
    Platta CS; Mackay C; Welsh JS
    Am J Clin Oncol; 2010 Aug; 33(4):408-19. PubMed ID: 19687730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of growth hormone on pituitary tumour growth.
    Herring R; Russell-Jones D
    Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas.
    Jaffrain-Rea ML; Di Stefano D; Minniti G; Esposito V; Bultrini A; Ferretti E; Santoro A; Faticanti Scucchi L; Gulino A; Cantore G
    Endocr Relat Cancer; 2002 Jun; 9(2):103-13. PubMed ID: 12121834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for adjunctive focused radiation therapy in pituitary adenomas.
    Knosp E; Perneczky A; Kitz K; Grunert P; Wild A
    Acta Neurochir Suppl; 1995; 63():81-4. PubMed ID: 7502734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferation parameters for pituitary adenomas.
    Buchfelder M; Fahlbusch R; Adams EF; Kiesewetter F; Thierauf P
    Acta Neurochir Suppl; 1996; 65():18-21. PubMed ID: 8738487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1.
    Abe T; Sanno N; Osamura YR; Matsumoto K
    Acta Neurochir (Wien); 1997; 139(7):613-8. PubMed ID: 9265953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA-flow cytometry of 207 pituitary adenomas: ploidy, proliferation, and prognosis.
    Machado AL; Nomikos P; Kiesewetter F; Fahlbusch R; Buchfelder M
    J Endocrinol Invest; 2005 Oct; 28(9):795-801. PubMed ID: 16370557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pituitary carcinoma.
    Sansur CA; Oldfield EH
    Semin Oncol; 2010 Dec; 37(6):591-3. PubMed ID: 21167378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.